13F filer · CIK 315066 ↗
Fidelity Investments
You are looking at Q2 2024. See the latest, Q2 2026 →
Reported value
$1.56T
+4.9% on the quarter before
Positions
5,362
466 new · 457 sold out
Top 10
36.0%
of the value
Est. gain
+$46.11B
on stocks held all quarter
Est. return
+3.2%
on those stocks since Q1 2024
Positions as of Jun 30, 2024, from Fidelity Investments's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 46% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2024. Striped tiles are options.
Largest buys
Since Q1 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Apple~$11.93BAdded · 3.3% → 4.7%+56,655,939 shares
- GE Vernova~$3.95BAdded · 0.0% → 0.3%+23,044,270 shares
- Amphenol~$3.25BAdded · 0.4% → 0.4%+48,269,314 shares
- Broadcom~$2.48BAdded · 0.5% → 0.8%+1,543,354 shares
- Oracle~$1.71BAdded · 0.2% → 0.4%+12,120,223 shares
- Canadian Nat Res Ltd~$1.47BAdded · 0.2% → 0.2%+41,285,067 shares
- Arista Networks~$1.23BAdded · 0.2% → 0.3%+3,516,491 shares
- Western Digital~$1.23BAdded · 0.0% → 0.1%+16,221,079 shares
- Qualcomm~$1.18BAdded · 0.1% → 0.2%+5,944,608 shares
- Micron~$1.10BAdded · 0.3% → 0.4%+8,350,687 shares
Largest sells
Since Q1 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Accenture Plc Ireland~$1.88BCut · 0.3% → 0.1%−6,202,025 shares
- Microsoft~$1.86BCut · 6.2% → 6.2%−4,172,715 shares
- Salesforce~$1.69BCut · 0.7% → 0.5%−6,565,681 shares
- Uber~$1.54BCut · 0.6% → 0.5%−21,191,048 shares
- Ishares Tr~$1.52BCut · 0.3% → 0.2%−2,769,865 shares
- Unitedhealth Group Inc~$1.51BCut · 1.2% → 1.1%−2,970,654 shares
- AMD~$1.01BCut · 0.5% → 0.3%−6,237,019 shares
- Vertiv~$994.4MCut · 0.2% → 0.1%−11,486,825 shares
- Eaton Corp Plc~$948.2MCut · 0.5% → 0.4%−3,023,936 shares
- Shockwave Med Inc~$842.1MSold out · 0.1% → 0.0%−2,586,054 shares
Holdings
As of Jun 30, 2024. Changes are in shares against Mar 31, 2024, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NvidiaCOM · shares +0.8% · price +23.1% | 8.3% | $128.96B | +$23.98B | ||||||||
| MicrosoftCOM · shares −1.9% · price +6.2% | 6.2% | $96.85B | +$5.68B | ||||||||
| AppleCOM · shares +20% · price +22.8% | 4.7% | $72.80B | +$11.31B | ||||||||
| MetaCL A · shares +1.2% · price +3.8% | 4.5% | $69.81B | +$2.55B | ||||||||
| AmazonCOM · shares +1.3% · price +7.1% | 4.1% | $63.64B | +$4.18B | ||||||||
| AlphabetCAP STK CL A · shares +0.9% · price +20.7% | 2.7% | $41.61B | +$7.07B | ||||||||
| Eli LillyCOM · shares −1.7% · price +16.4% | 1.9% | $30.32B | +$4.27B | ||||||||
| Berkshire Hathaway Inc DelCL A · shares 0% · price −3.5% | 1.3% | $20.47B | −$742.1M | ||||||||
| AlphabetCAP STK CL C · shares +0.5% · price +20.5% | 1.3% | $20.02B | +$3.38B | ||||||||
| Exxon Mobil CorpCOM · shares +6.2% · price −1.0% | 1.1% | $17.44B | −$159.8M | ||||||||
| Unitedhealth Group IncCOM · shares −8.3% · price +2.9% | 1.1% | $16.65B | +$476.1M | ||||||||
| NetflixCOM · shares +1.0% · price +11.1% | 0.92% | $14.33B | +$1.42B | ||||||||
| Visa Inc.COM CL A · shares +1.5% · price −6.0% | 0.90% | $14.13B | −$881.5M | ||||||||
| BroadcomCOM · shares +26% · price +21.1% | 0.76% | $11.88B | +$1.64B | ||||||||
| Wells Fargo Co NewCOM · shares +1.2% · price +2.5% | 0.72% | $11.23B | +$267.1M | ||||||||
| Regeneron PharmaceuticalsCOM · shares −1.3% · price +9.2% | 0.72% | $11.19B | +$942.9M | ||||||||
| Boston Scientific CorpCOM · shares −0.3% · price +12.4% | 0.70% | $10.89B | +$1.21B | ||||||||
| Ge AerospaceCOM NEW · shares −2.0% · price −9.4% | 0.69% | $10.76B | −$1.12B | ||||||||
| Jpmorgan Chase & Co.COM · shares −4.1% · price +1.0% | 0.69% | $10.74B | +$104.1M | ||||||||
| MastercardCL A · shares −0.9% · price −8.4% | 0.58% | $9.11B | −$834.6M | ||||||||
| Marvell Technology IncCOM · shares −0.02% · price −1.4% | 0.58% | $9.08B | −$127.3M | ||||||||
| TSMCSPONSORED ADS · shares +12% · price +27.8% | 0.58% | $9.07B | +$1.76B | ||||||||
| Bank America CorpCOM · shares +4.4% · price +4.9% | 0.51% | $7.96B | +$354.9M | ||||||||
| SalesforceCOM · shares −18% · price −14.6% | 0.50% | $7.80B | −$1.34B | ||||||||
| Costco Whsl Corp NewCOM · shares −3.1% · price +16.0% | 0.49% | $7.64B | +$1.05B | ||||||||
| Total · 5,362 positions | 100% | $1.56T | +$46.11B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2024 to Q2 2024: 4,746 stocks held throughout, up $46.11B (+3.2%).
- Nvidia9:1 split+$23.98B+23%
- Apple+$11.31B+23%
- Alphabet+$7.07B+21%
- Microsoft+$5.68B+6%
- Eli Lilly+$4.27B+16%
- Ge Aerospace−$1.12B−9%
- Salesforce−$1.34B−15%
- Lululemon Athletica Inc−$1.65B−24%
- Canadian Nat Res Ltd−$1.81B−53%
- Amphenol−$2.58B−42%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 17 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $2.30T+21% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.90T−3% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $1.96T+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $1.92T+8% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $1.77T+13% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.57T−7% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $1.68T+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $1.64T+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $1.56T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.49T+14% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $1.30T+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $1.16T−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $1.19T−45% | SEC ↗ |
| Q1 2023 | May 11, 2023 (amended) | $2.19T+117% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $1.01T+5% | SEC ↗ |
| Q3 2022 | Nov 10, 2022 | $958.93B−4% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $1.00T−20% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $1.25T−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $1.35T+7% | SEC ↗ |
| Q3 2021 | Feb 14, 2022 (amended) | $1.26T−1% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $1.28T+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $1.17T+4% | SEC ↗ |
| Q4 2020 | Feb 8, 2021 | $1.12T+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $989.33B+9% | SEC ↗ |
| Q2 2020 | Aug 24, 2020 (amended) | $909.48B+26% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $722.13B−20% | SEC ↗ |
| Q4 2019 | Feb 7, 2020 | $906.40B+9% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $833.77B−3% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $856.19B+3% | SEC ↗ |
| Q1 2019 | May 13, 2019 (amended) | $834.93B+14% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $730.25B−18% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $888.88B+2% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 (amended) | $868.68B+3% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $842.35B−1% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $853.06B+3% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $827.12B+3% | SEC ↗ |
| Q2 2017 | Aug 29, 2017 (amended) | $804.55B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $787.10B+5% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 (amended) | $748.25B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $750.86B+2% | SEC ↗ |
| Q2 2016 | Aug 11, 2016 | $732.58B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $722.80B | SEC ↗ |
